Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: QUESTIONS

RE: QUESTIONS

posted on Apr 24, 2006 07:47AM

added lucky number 13 below...

13) Do we have any direct or indirect customers for the Ignite program? More than one?

If yes, when will there be product on the market utilizing Ignite?

John

PS (sorry OZ) #14 Can you guy just buy EDIG and force TPL to play in their sandbox? lol

********************************************

1). We know the patents are good until 2015, are they like pharma companies and are no good after that, or are they simular to other tech patents....that is are they renewable if used. We are selling licenses to them so they are not shelved, and subjet to expire worthless. Can they be renewed?

2). With question number 1 comes a related question, the licences` we make, are some going to have reoccurring royalties and in having such, will they continue beyond 2015?

3). Does the company plan to settle with Fish with some sort of lessor agrement, or are we going the distance and try to win and outrigh dismissal?......and your reason for the answer.

4). We were extremely excited about he ``dozens`` comment in the PRs, with such a comment we had though there may be at least a couple more deal made by now....was the comment premature and are the companies refered to now stalling?...or are we stalling and demanding more money now the Fuji settled.

5). We know Sony Corp. is not a part of the suits anymore, is that because of their relationship with our attorneys, and if so, is TPL looking for another firm to go after them?

6). TPL, being a private company, may have different outlooks on results than do we as a public company. Is management 100% satisified with TPL`s honor, intergity and efforts to keep in mind PTSC`s intrests when making deals?

7). If and when we get the Fish lawsuit behind us, does the company plan to continue dividends on a quartly basis, as deal come in....or does the company plan to do a share buyback......or thirdly, does the company plan to ues the cash for company expantion?

8). Would management be willing to tie the manage incentive plan, shares you are getting for yourself, to the upward movement in share price?

9). Are Swartz and Lincon any problem for the company?

10). TPL is working on other branches of their company, some shareholders have beging the think that just maybe PTSC might venture into another business partnership with them to market and advance the Ignite and Inflame tech......is this a reasonable conjecture and weahter Ignite and Inflame are involved or not, do you forsee us ever making another partnership with them?

11) Is there any reason why the next SHM will be in six months(Oct06)?

12) oh, and what about plans to get to Nasdaq?

13) Do we have any direct or indirect customers for the Ignite program? More than one?

If yes, when will there be product on the market

utilizing Ignite?

Share
New Message
Please login to post a reply